Accolade — Merger or Acquisition (January 2021)
22 slides from Accolade's merger presentation, Jan 14, 2021
Slide 1: Accolade Announces Acquisition of 2nd.MD
1 1 AccoladeAnnounces Acquisitionof2nd.MD
Slide 2: Forward-looking statements
2 2 2 2 This presentation contains “forward-looking statements” –that is, statements related to future, not past, events. In this context, forward-looking statements often address our expected future business and financial performance and financial condition, and often contain words such ‘‘anticipat
Slide 3: Today's Presenters
Today’sPresenters Rajeev Singh Chief Executive Officer Accolade Steve Barnes Chief Financial Officer Accolade Jason Melton Chief Executive Officer 2nd.MD 3 3
Slide 4: Integrating expert healthcare resources into a single solution
4 Integrating expert healthcare resources into a single solution that simplifies the care journey and empowers people to make the best decisions for their health and well-being. 4
Slide 5: Combining two market leading platforms
Combiningtwomarketleadingplatforms To create the industry’s most comprehensive, integrated healthcare navigation experience. -Leader in personalized health and benefits -Relationship-based clinical model that persists throughout care journeys -Expanding platform of clinical programs that improve cli
Slide 6: Delivering Medical Certainty and Driving Savings
DeliveringMedicalCertaintyandDrivingSavings Accolade Creates Impact Across the Entire Consumer Journey treatment costs Engage in care management Annual Open Enrollment Research plan options Receive benefit card Enroll in plan Understand benefits Review health benefits Manage Rx Enroll in point solut
Slide 7: Integrating Expert Medical Opinion Further Lowers Unnecessary Healthcare Utilization
IntegratingExpertMedicalOpinion Further Lowers Unnecessary Healthcare Utilization Example: Improving knee pain-related utilization trends Right Member Right Decision Right Path I M P A C T Improved outcomes, satisfaction and trust -Machine learning model proactively identifies members with high risk
Slide 8: Solution Portfolio Delivering Comprehensive, Integrated and Clinical Support
SolutionPortfolio Delivering Comprehensive, Integrated and Clinical Support Accolade Total Benefits Accolade Total Care Accolade Total Health and Benefits Navigation Provider Decision SupportIntegrated Population Health SO L U T I O NF E A T U R E SSO L U T I O NF E A T U R E SSO L U T I O NF E A T
Slide 9: Accelerating Accolade's Clinical Innovation Lowering Healthcare Spend
AcceleratingAccolade’sClinical Innovation Lowering Healthcare Spend 2021 2007 - 2019 JUNE 2020 SEPTEMBER Launched Mental Health Integrated Care OCTOBER Global Appropriateness Measures group partnership JANUARY Adding 2nd.MD Expert Medical Opinion Created a Proven High Touch, High Tech Personalized A
Slide 10: Overview
10 10 Overview
Slide 11: Our Inspiration: Clint and Gabi
11 11 11 11 14 14 14 14 OUR INSPIRATION Clint and Gabi
Slide 12: State of Healthcare
STATE OF HEALTHCARE 17 30% • The average US doctor is 17 years behind research • 30% of healthcare spending is wasted • Specialist wait times have reached 60 days in some cities • Doctors spend 1 minute on average discussing treatment 5% of employees = 50% of costs 60 days Healthcare costs rise with
Slide 13: Expert-led consultations vs. alternatives
VS. • Live video consultations • Expert led (nurse, records team, elite specialist) • Answers in 3 to 5 days 13 13 13 13
Slide 14: Impact of 2nd.MD
IMPACT OF 2ND.MD 85%35% $27K 14 14 14 14 improved treatment plans 30% of surgery consults result in surgery cancellation of consults lead to an alternate diagnosis +91 Net Promoter Score savings per surgical consult $5K+ savings per consult
Slide 15: Expert Medical Consultation
EXPERT MEDICAL CONSULTATION Providing members with confidence in their diagnosis and treatment plan in 3 to 5 days Initial contact / care team RN member intake Records collected and curated by 2nd.MD Recommend specialist physician & schedule consultation 30+ minute live consultation with specialist
Slide 16: Personalized, Virtual Consultations
PERSONALIZED, VIRTUAL CONSULTATIONS
Slide 17: Directly Address Major Cost Drivers
DIRECTLY ADDRESS MAJOR COST DRIVERS Top Conditions Cited by Employers Driving Cost % of respondents ranking condition category as a top 3 cost driver 2nd.MD Average Savings Per Case Musculoskeletal Cancer Cardiovascular Mental Health 9% 39% 78% 90% $32K $33K $39K $7K 17 17 17 17
Slide 18: Transaction Details
AMaccolade | €92nd.MD Transaction Details
Slide 19: Total Customers and $46BN TAM
Total Customers $46BN TAM ~400 $22BN Expert Medical Opinion 94 54 1520 FY201 8FY201 9FY202 0As of 10/19/20Pro Form a Combi ned $24BN Advocacy Market 19 19
Slide 20: Total Consideration: Up to $460 million
20 Total Consideration:Up to $460 million Cash:$230 million Stock:$130 million in common stock (2.82 million shares) Contingent stock consideration:Up to $100 million in common stock (2.17 million shares), subject to achievement of defined revenue milestones Estimated close date:Estimated by the end
Slide 21: Transaction rationale
21 Adds Expert Medical Opinion capabilities, a highly desired employer healthcare benefit 900 leading expert medical specialists across all specialty areas ~400 customers covering 9 million+ members, with virtually zero customer overlap, provides opportunity for cross-sell and up-sell $Compelling va
Slide 22: Accolade | 2nd.MD
AMaccolade | €32nd.MD